Common problems in the diagnosis and treatment of Wilson's disease;Problemas frecuentes en el diagnóstico y tratamiento de la enfermedad de Wilson

Gastroenterologia y Hepatologia

Volumn 36, Issue 5, 2013, Pages 316-325

  Bruguera, Miguel ^a,b   Abraldes, Juan G ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Copper; Cupriuria; Penicillamine; Trientine; Zinc

Indexed keywords

ARTICLE; HUMAN; PHYSICIAN; WILSON DISEASE;

ALGORITHMS; HEPATOLENTICULAR DEGENERATION; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84877632563     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2012.10.003     Document Type: Article

References (83)

1. Roberts E.A., Schilsky M. American Association for the Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 2008, 47:2089-2111.
2. Schilsky M., Ala A. Genetic testing for Wilson disease: availability and utility. Curr Gastroenterol Rep 2010, 12:57-61.
3. Badenas Orquin C. Avances en el diagnóstico molecular de la enfermedad de Wilson. Gastroenterol Hepatol 2011, 34:428-433.
4. Bennett J., Hahn S.H. Clinical molecular diagnosis of Wilson disease. Semin Liver Dis 2011, 31:233-238.
5. Ferenci P., Caca K., Loudianos G., Mieli-Vergani G., Tanner S., Sternlieb I., et al. Diagnostic and phenotypic classification of Wilson disease. Liver Int 2003, 23:139-142.
6. Xuan A., Bookman I., Cox D.W., Heathcote J. Three atypical cases of Wilson disease: assessment of the Leipzig scoring system in making a diagnosis. J Hepatol 2007, 47:428-433.
7. Muller T., Koppikar S., Taylor R.M., Carragher P., Schlenck B., Heinz-Erian P., et al. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children. J Hepatol 2007, 47:270-276.
8. Dhawan A., Taylor R.M., Cheeseman P., de Silva P., Katsiyiannakis L., Mieli-Vergani G. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl 2005, 11:441-448.
9. Walshe J.M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med 1956, 21:487-495.
10. Walshe J.M. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982, 1:643-647.
11. Hoogenraad T.U. Zinc treatment of Wilson's disease. J Lab Clin Med 1998, 132:240-241.
12. Brewer G.J., Askari F., Lorincz M.T., Carlson M., Schilsky M., Kluin K.J., et al. Treatment of Wilson disease with ammonium tetrathiomolybdate. IV Comparison of tetrathiomolybdate and trientine in a double blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol 2000, 63:521-527.
13. Bruha R., Marecek Z., Pospisilova L., Nevsimalova S., Vitek L., Martasek P., et al. Long-term follow-up of Wilson disease: natural history, treatment, mutation analysis and phenotypic correlation. Liver Int 2012, 31:83-89.
14. Xu X., Pin S., Gathinji M., Fuchs R., Harris Z.L. Aceruloplasminemia: an inherited neurogenerative disease with impairment of iron homeostasis. Ann N Y Acad Sci 2004, 1012:299-305.
15. Schilsky M.L., Sternlieb I. Overcoming obstacles to the diagnosis of Wilson's disease. Gastroenterology 1997, 113:350-353.
16. Merle U., Eisenbach C., Weiss K.H., Tuma S., Stremmel W. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease. J Hepatol 2009, 51:925-930.
17. Schilsky M.L. Non-invasive testing for Wilson disease: revisiting the d-penicillamine challenge test. J Hepatol 2007, 47:172-173.
18. Martins da Costa C., Baldwin D., Portmann B., Lolin Y., Mowat A.P., Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 1992, 15:609-615.
19. Iorio R., Porzio S., Mazzarella G., Fasco G., Veguente A. Wilson's disease diagnostic dilemmas?. J Pediat Gastroenterol Nutr 2000, 38:186-190.
20. Nicastro E., Ranucci G., Vajro P., Vegnente A., Iorio R. Re-evaluation of the diagnosis criteria for Wilson disease in children with mild liver disease. Hepatology 2012, 52:1948-1956.
21. Ross M.E., Jacobson I.M., Dienstag J.L., Martin J.B. Late-onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings. Ann Neurol 1985, 17:411-413.
22. Esmaeli B., Burnstine M.A., Martonyi C.L., Sugar A., Johnson V., Brewer G.J. Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson's disease. Cornea 1996, 15:582-588.
23. Fleming C.R., Dickson E.R., Wahner H.W., Hollenhorst R.W., McCall J.T. Pigmented corneal rings in non-Wilsonian liver disease. Ann Intern Med 1977, 86:285-288.
24. Pellecchia M.T., Criscuolo C., Longo K., Campanella G., Filla A., Barone P., et al. Clinical presentation and treatment of Wilson's disease: a single-centre experience. Eur Neurology 2003, 50:48-52.
25. Oder W., Grimm G., Kollegger H., Ferenci P., Schneider B., Deecke L. Neurological and neuropschyatric spectrum of Wilson's disease. A prospective study of 45 cases. J Neurol 1991, 238:281-287.
26. del Rosario M.A., Davis M.M., Chong S.K. Wobbly handwriting. Lancet 1998, 351:336.
27. Johncilla M., Mitchell K.A. Pathology of the liver in copper overload. Semin Liver Dis 2011, 31:239-244.
28. Ludwig J., Moyer T.P., Rakela J. The liver biopsy diagnosis of Wilson's disease. Methods in pathology. Am J Clin Pathol 1994, 102:443-446.
29. Pilloni L., Lecca S., van Eyken P., Fiore C., Demella L., Pilleri G., et al. Value of histochemical stains for copper in the diagnosis of Wilson's disease. Histopathology 1998, 33:28-33.
30. Nemolato S., Serra D., Saccani S., Faa G. Deparaffination time: a crucial point in histochermical detection of tissue copper. Eur J Histochem 2008, 52:175-178.
31. Ferenci P., Steindl-Munda P., Vogel W., Jessner W., Gschwantler M., Stauber R., et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease. Clin Gastroenterol Hepatol 2005, 3:811-818.
32. Masson J., McQuaid A., Pheiffer H. Can Wilson's disease patients be decoppered?. Lancet 1989, 1:1455.
33. Wong R.J., Gish R., Schilsky M., Frenette C. A clinical assessment of Wilson disease in patients with concurrent liver disease. J Clin Gastroenterol 2011, 45:267-273.
34. Yenmer S., Akarseu M., Karacanci C., Sengul B., Topalak O., Biberoglu K., et al. Wilson's disease with coexisting autoimmune hepatitis. J Gastroenterol Hepatol 2004, 19:114-116.
35. Ala A., Borjigin J., Rochwarger A., Schilsky M. Wilson disease in septuagenarian siblings. Raising bar the diagnosins. Hepatology 2005, 41:668-670.
36. Durand F. Wilson's disease: an old disease keeps its old secrets. Eur J Gastroenterol Hepatol 2007, 19:7-9.
37. Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 2006, 120:151-159.
38. Schmidt H.H.J. Role of genotyping in Wilson's disease. J Hepatol 2009, 50:449-452.
39. Walshe J.M., Dixon A.K. Dangers of non-compliance in Wilson's disease. Lancet 1986, 8485:845-847.
40. McCullough AJ, Fleming CR, Thistle JL, Baldus WP, Ludwig J, McCall JT, et al. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology. 1983;84:161-7.
41. Berman D.H., Leventhal R.I., Gavaler J.S., Cadoff E.M., van Thiel D.H. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991, 100:1129-1134.
42. Shaver W.A., Bhatt H., Combes B. Low serum alkaline phosphatase activity in Wilson's disease. Hepatology 1986, 5:859-863.
43. Korman J.D.F., Volenberg I., Balko J., Webster J., Schiodt F.V., Squires R.H., et al. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology 2008, 48:1167-1174.
44. Chen W.S., Govindarajan S., Redeker A.G. Hepatocellular carcinoma in a case of Wilson's disease. Liver 1992, 12:42-45.
45. Czlonkowska A., Gajda J., Rodo N. Effects of long-term treatment in Wilson's disease with d-penicillamine and zinc sulphate. J Neurol 1996, 243:269-273.
46. Marcellini M., di Ciommo V., Callea F., Devito R., Comparcola D., Sartorelli M.R., et al. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J Lab Clin Med 2005, 145:139-144.
47. Medici V., Trevisan C.P., D'Incà R., Barollo M., Zancan L., Fagiuoli S., et al. Diagnosis and management of Wilson's disease: results of a single center experience. J Clin Gastroenterol 2006, 40:936-941.
48. Schilsky M.L. Treatment of Wilson's disease: what are the relative roles of penicllamine, trientine and zinc supplermentation. Curr Gastroenterol Rep 2001, 3:54-59.
49. Brewer G.J. Novel therapeutic approaches to the treatment of Wilson disease. Expert Opin Pharmacother 2006, 7:317-324.
50. Lee V.D., Northup P.G., Berg C.L. Resolution of decompensated cirrhosis from Wilson's disease with zinc monotherapy: a potential therapeutic option. Clin Gastroenterol Hepatol 2006, 4:1069-1071.
51. Walshe J.M., Munro N.A. Zinc-induced deterioration in Wilson's disease aborted by treatment with penicillamine, dimercaprol, a novel zero copper diet. Arch Neurol 1995, 52:10-11.
52. Lang C.J., Rabas-Kolominski P., Engelhardt A., et al. Fatal deterioration of Wilson's disease after institution of oral zinc therapy. Arch Neurol 1993, 50:1007-1008.
53. Weiss K.H., Gotthardt D.N., Klemm D., Merle U., Ferenci- Foerster D., Schaefer M., et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology 2011, 140:1189-1198.
54. Santos Silva E.E., Sarles J., Buts J.P., Sokal E.M. Successful medical treatment of severely decompensated Wilson disease. J Pediatr 1996, 128:285-287.
55. Askari F.K., Greenson J., Dick R.D., Johnson V.D., Brewer G.J. Treatment of Wilson's disease with zinc, XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc. J Lab Clin Med 2003, 142:385-390.
56. Fox A., Schilsky M. Once daily trientine for maintenance therapy of Wilson disease. Am J Gastroenterol 2008, 103:494-495.
57. van den Hamer C.J., Hoogenraad T.U. Copper deficiency in Wilson's disease. Lancet 1989, 2:44.
58. Foubert- Samier A., Kazadi A., Rouanet M., Vital A., Lagueny A., Tison F. Axonal sensory motor neuropathy in copper-deficient Wilson's disease. Muscle & Nerve 2009, 40:294-296.
59. da Silva-Junior F.P., Machado A.A.C., Lucato L.T., Cançado E.L.R., Barbosa E.R. Copper deficiency myeloneuropathy in a patient with Wilson disease. Neurology 2011, 76:1673-1674.
60. Cortese A., Zangaglia R., Lozza A., Piccolo G., Pacchetti C. Copper deficiency in Wilson's disease: peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment. Mov Dis 2011, 26:1361-1362.
61. Horvath J., Beris P., Giostra E., Martin P.-Y., Burkhard P.R. Zinc-induced copper deficiency in Wilson disease. J Neurol Neurosurg Psychiatry 2010, 81:1410-1411.
62. Lozano Herrero J., Muñoz Bertran E., Ortega Gonzalez I., Gomez Espín R., Lopez Espín M.I. Myelopathy secondary to ciopper deficiency as a complicaction of treatment of Wilson's disease. Gastroenterol Hepatol 2012, 35:704-707.
63. Iorio R., d'Ambrosi M., Marcellini M., Barbera C., Maggiore G., Zancan L., et al. Serum transaminases in children with Wilson's disease. J Pediatr Gastroenterol Nutr 2004, 39:331-336.
64. Shiono Y., Wakusawa S., Hayashi H., Takikawa T., Yano M., Okada T., et al. Iron accumulation in the liver of male patients with Wilson's disease. Am J Gastroenterol 2001, 96:3147-3151.
65. Medici V., di Leo V., Lamboglia F., Bowlus C.L., Tseng S.C., D'Incà R., et al. Effect of penicillamine and zinc on iron metabolism in Wilson's disease. Scand J Gastroenterol 2007, 42:1495-1500.
66. Erhardt A., Hoffmann A., Hefter H., Häussinger D. HFE gene mutations and iron metabolism in Wilson's disease. Liver 2002, 22:474-478.
67. Morris H., Ikeda S., Yamamoto K., Morita H., Morita S., Yoshida K., et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 1995, 57:646-656.
68. Amon R., Calderon J.F., Schilsky M., Emser S., Shneider B.L. Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine). J Pediatr Gastroenterol Nutr 2007, 44:596-602.
69. Masselbas W., Chabik G., Czlonkowska A. Persistence with treatment in patients with Wilson disease. Neurol Neurochir Pol 2010, 44:260-263.
70. Yonezawa K., Nunomiya S., Daigo M., Ogra Y., Suzuki K.T., Enomoto K., et al. Soy protein isolate enhances hepatic copper accumulation and cell damage in LEC rats. J Nutr 2003, 133:1250-1254.
71. Catana A.M., Medici V. Liver transplantation for Wilson disease. World J Hepatol 2012, 4:5-10.
72. Brewer G.J., Askari F. Transplant livers in Wilson's disease for hepatic, non neurologic, indications. Liver transplantation 2000, 6:662-664.
73. Duarte Royo A., Zepeda Gomez S., Garcia Leiva J., Remes Troche J.M., Angeles Angeles A., Torre Delgadillo A., et al. Liver transplantation for neurological Wilson's disease: reflections on two cases within a mexican cohort. Rev Gastroenterol Mex 2009, 74:218-223.
74. Schumacher G., Platz K.P., Mueller A.R., Neuhaus R., Luck W., Langrehr J.M. Liver transplantation in neurologic Wilson's disease. Tranplant Proc 2001, 33:1518-1519.
75. Cheung F., Li X.C., Sun B.C., Kong L.B. Outcomes of living-related liver transplantation for Wilson disease: a single-center experience. Transplantation 2009, 87:751-757.
76. Tatsumi Y., Hattori A., Hayashi H., Ikoma J., Kaito M., Imoto M., et al. Current state of Wilson disease patients in central Japan. Intern Med 2010, 49:809-815.
77. Shimono N., Ishibashi H., Ikematsu H., Kudo J., Shirahama M., Inabra S., et al. Fulminant hepatic failure during perinatal period in a pregnant women with Wilson's disease. Gastroenterol Jpn 1991, 26:69-73.
78. Brewer G.J., Johnson V.D., Dick R.D., Hedera P., Fink J.K., Kluin J.J. Treatmen t of Wilson disease with zinc, XVII: treatment during pregnancy. Hepatology 2000, 31:364-370.
79. Sternlieb I. Wilson's disease and pregnancy. Hepatology 2000, 31:531-532.
80. Walshe J.M. The management of pregnancy in Wilson's disease treated with trientine. Q J Med 1986, 58:81-87.
81. Haimov-Kochman R., Ackerman Z., Anteby E.Y. The contraceptive choice for a Wilson's disease patient with chronic liver disease. Contraception 1997, 56:241-244.
82. Rubinfeld Y., Maor Y., Simon D., Modai D. A progressive rise in serum copper levels in women taking oral contraceptives: a potential hazard?. Fertil Steril 1979, 32:599-601.
83. Walshe J.M. Cause of death in Wilson disease. Mov Disord 2007, 22:2216-2220.